RANDOMIZED PHASE II CLINICAL TRIAL OF TAILORED IRINOTECAN (CPT-11) PLUS S-1 VERSUS S-1 IN PATIENTS WITH ADVANCED OR RECURRENT GASTRIC CARCINOMA AS THE FIRST-LINE CHEMOTHERAPY (THE JAPANESE FOUNDATION FOR MULTIDISCIPLINARY TREATMENT OF CANCER, JFMC31-0301)

被引：0
|
作者：
Takahashi, Y. [1 ]
Komatsu, Y. [2 ]
Kitajima, M. [3 ]
Kubota, T. [4 ]
Saji, S. [5 ]
Nishiyama, M. [6 ]
Kimura, Y. [7 ]
Oda, H. [8 ]
Tajima, Y. [9 ]
Miki, H. [10 ]
机构：
[1] Chiba Univ, Chiba, Japan
[2] Hokkaido Univ Hosp, Ctr Canc, Sapporo, Hokkaido 060, Japan
[3] Int Univ Hlth & WelfareS, Tokyo, Japan
[4] Keio Univ, Ctr Comprehens & Adv Med, Tokyo, Japan
[5] Japanese Fdn Multidisciplinary Treatment Canc, Tokyo, Japan
[6] Saitma Med Univ, Int Med Ctr, Translat Tesearch Ctr, Hidaka, Saitama, Japan
[7] NTT W Osaka Hosp, Osaka, Japan
[8] Kushiro Rosai Hosp, Kushiro, Hokkaido, Japan
[9] Showa Univ, Sch Med, Tokyo 142, Japan
[10] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [31] Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)
    Keun-Wook Lee
    Ik-Joo Chung
    Min-Hee Ryu
    Young Iee Park
    Byung-Ho Nam
    Ho-Suk Oh
    Kyung Hee Lee
    Hye Sook Han
    Bong-Gun Seo
    Jae-Cheol Jo
    Hyo Rak Lee
    Jin Won Kim
    Sook Ryun Park
    Sang Hee Cho
    Yoon-Koo Kang
    Gastric Cancer, 2021, 24 : 156 - 167
  • [32] Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
    X. Wang
    M. L. Wang
    L. Y. Zhou
    X. Y. Lu
    J. F. Yang
    H. G. Yu
    Clinical and Translational Oncology, 2013, 15 : 836 - 842
  • [33] Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
    Wang, X.
    Wang, M. L.
    Zhou, L. Y.
    Lu, X. Y.
    Yang, J. F.
    Yu, H. G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (10): : 836 - 842
  • [34] Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer
    Tsutani, Yasuhiro
    Ohara, Masahiro
    Suzuki, Takahisa
    Minami, Kazuhito
    Miyahara, Eiji
    Kameda, Akira
    Noso, Yoshihiro
    ANTICANCER RESEARCH, 2009, 29 (07) : 2775 - 2779
  • [35] Pilot study of simplified low-dose S-1 plus CPT-11 as first-line chemotherapy for patients with advanced colorectal cancer
    Yoshimatsu, Kazuhiko
    Yokomizo, Hajime
    Fujimoto, Takashi
    Umehara, Arihiro
    Otani, Taisuke
    Matsumoto, Atsuo
    Osawa, Gakuji
    Ogawa, Kenji
    ANTICANCER RESEARCH, 2007, 27 (3B) : 1657 - 1661
  • [36] Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002)
    Takiuchi, H
    Narahara, H
    Tsujinaka, T
    Gotoh, M
    Kawabe, S
    Katsu, K
    Iishi, H
    Tatsuta, M
    Fujitani, K
    Furukawa, H
    Taguchi, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (09) : 520 - 525
  • [37] Apatinib in combination with S-1 as first-line treatment in patients with advanced gastric cancer: A phase II clinical trial.
    Zhang, Chuantao
    Liu, Zimin
    Zhou, Na
    Zhang, Jianli
    Zhu, Jingjuan
    Lv, Hongying
    Li, Tianjun
    Hou, Helei
    Liu, Dong
    Cong, Jing
    Jiang, Man
    Liu, Kewei
    Cui, Zhumei
    Zhou, Yanbing
    Zhang, Xiaochun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [38] Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
    Narahara, Hiroyuki
    Iishi, Hiroyasu
    Imamura, Hiroshi
    Tsuburaya, Akira
    Chin, Keisho
    Imamoto, Haruhiko
    Esaki, Taito
    Furukawa, Hiroshi
    Hamada, Chikuma
    Sakata, Yuh
    GASTRIC CANCER, 2011, 14 (01) : 72 - 80
  • [39] Irinotecan plus S-1 (IRIS) versus S-1 alone as first line treatment for advanced gastric cancer: Preliminary results of a randomized phase III study (GC0301/TOP-002)
    Chin, K.
    Iishi, H.
    Imamura, H.
    Kobayashi, O.
    Imamoto, H.
    Esaki, T.
    Kato, M.
    Tanaka, Y.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
    Hiroyuki Narahara
    Hiroyasu Iishi
    Hiroshi Imamura
    Akira Tsuburaya
    Keisho Chin
    Haruhiko Imamoto
    Taito Esaki
    Hiroshi Furukawa
    Chikuma Hamada
    Yuh Sakata
    Gastric Cancer, 2011, 14 : 72 - 80
12345